Investors Overview

Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products directly in Canada and indirectly through partners in the U.S., and South America. Cipher is focused on building strategic sales and distribution partnerships, out licensing products and selective investments in drug development to assemble a broad portfolio of prescription products that serve unmet medical needs. 

Annual Reports

2017 Annual Report

Financial Reports

Quarterly Reports

Events & Webcasts

View a listing of our recent events and webcasts

Wednesday, June 23, 2021
10:00am EDT